WO2007069070A3 - Aseptically filled multidose injectable dosage forms of granisetron - Google Patents
Aseptically filled multidose injectable dosage forms of granisetron Download PDFInfo
- Publication number
- WO2007069070A3 WO2007069070A3 PCT/IB2006/003661 IB2006003661W WO2007069070A3 WO 2007069070 A3 WO2007069070 A3 WO 2007069070A3 IB 2006003661 W IB2006003661 W IB 2006003661W WO 2007069070 A3 WO2007069070 A3 WO 2007069070A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- granisetron
- multidose
- dosage forms
- aseptically filled
- injectable dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
Abstract
The present invention relates to aseptically filled multidose injectable dosage forms of granisetron or salts thereof, and processes for their preparation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1587MU2005 | 2005-12-16 | ||
IN1587/MUM/05 | 2005-12-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007069070A2 WO2007069070A2 (en) | 2007-06-21 |
WO2007069070A3 true WO2007069070A3 (en) | 2009-04-16 |
Family
ID=38163289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/003661 WO2007069070A2 (en) | 2005-12-16 | 2006-12-18 | Aseptically filled multidose injectable dosage forms of granisetron |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007069070A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI372057B (en) | 2008-12-11 | 2012-09-11 | Dev Center Biotechnology | Sustained release implant for granisetron |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060211982A1 (en) * | 2002-12-20 | 2006-09-21 | Steven Prestrelski | Intracutaneous injection |
US20070015808A1 (en) * | 2005-07-13 | 2007-01-18 | Baxter International Inc. | Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3. 1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride |
-
2006
- 2006-12-18 WO PCT/IB2006/003661 patent/WO2007069070A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060211982A1 (en) * | 2002-12-20 | 2006-09-21 | Steven Prestrelski | Intracutaneous injection |
US20070015808A1 (en) * | 2005-07-13 | 2007-01-18 | Baxter International Inc. | Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3. 1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
WO2007069070A2 (en) | 2007-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
WO2009016564A3 (en) | 2-aza-bicyclo[3.3.0]octane derivatives | |
WO2010037059A3 (en) | Heteroaryl antagonists of prostaglandin d2 receptors | |
MX2010005889A (en) | Novel thiophene derivatives. | |
WO2010057118A3 (en) | Heterocyclic antagonists of prostaglandin d2 receptors | |
WO2008115281A3 (en) | Compounds for treating viral infections | |
WO2007086001A3 (en) | Novel pyridine derivatives | |
WO2008081399A3 (en) | 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists | |
MX2010004576A (en) | Novel pyrimidine derivatives. | |
WO2010039977A3 (en) | Heteroaryl antagonists of prostaglandin d2 receptors | |
WO2011041694A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
WO2011017350A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2009016560A3 (en) | Trans-3-aza-bicyclo[3.1.0]hexane derivatives | |
PT2364983E (en) | Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same | |
WO2011057262A3 (en) | Treatment of infections with tp receptor antagonists | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2011160024A3 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
WO2009089234A3 (en) | Substituted dibenzhydrylpiperazines | |
EA201000039A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING SOLIFENACIN OR ITS PHARMACEUTICALLY ADAPTABLE SALT | |
SI2238110T1 (en) | 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors | |
WO2008051539A3 (en) | Processes for preparing palonosetron salts | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
WO2010077976A3 (en) | Prokineticin receptor antagonists and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1225/MUMNP/2008 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06831743 Country of ref document: EP Kind code of ref document: A2 |